Berlin, Germany

Marianne Fahnrich

This inventor holds 8 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1989-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marianne Fahnrich. Retrieved from https://idiyas.com/inventor/marianne-fahnrich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 87.5

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1989-2007

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Marianne Fahnrich: A Trailblazer in Technological Innovation

Introduction:

Marianne Fahnrich, a brilliant inventor based in Berlin, DE, has left an indelible mark on the world of technology with his inventive spirit and dedication to pushing boundaries.

Latest Patents:

With an impressive portfolio of 8 patents, Fahnrich's latest inventions include Vitamin D derivatives with carbo- or heterocyclic substituents at C-25. These compounds hold great promise in the treatment of various diseases ranging from skin conditions to degenerative diseases of the nervous system.

Career Highlights:

Fahnrich's career flourished at Schering Aktiengesellschaft, where he honed his skills and expertise in the field of pharmaceuticals. His innovative approach towards research and development led to groundbreaking discoveries that have the potential to revolutionize the medical industry.

Collaborations:

Throughout his career, Fahnrich collaborated with esteemed professionals such as Andreas Steinmeyer and Gerald Kirsch. Together, they worked on cutting-edge projects that have paved the way for advancements in medicine and healthcare.

Conclusion:

In conclusion, Marianne Fahnrich's unwavering commitment to innovation and his relentless pursuit of excellence continue to inspire positive change in the technological landscape. His remarkable contributions have not only enriched the field of pharmaceuticals but also have the potential to improve the quality of life for countless individuals worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…